Charles River Laboratories to Present at UBS and Jefferies Conferences
2024年11月11日 - 10:00PM
ビジネスワイヤ（英語）
Charles River Laboratories International, Inc. (NYSE: CRL)
announced today that it will present at the UBS Global Healthcare
Conference on Tuesday, November 12th, at 10:15 a.m. PT (1:15 p.m.
ET), and the Jefferies London Healthcare Conference on Wednesday,
November 20th, at 2:00 p.m. GMT (9:00 a.m. ET).
Management will provide an overview of Charles River’s strategic
focus, business developments, and recent trends.
A live webcast of each presentation will be available through a
link that will be posted on the Investor Relations section of the
Charles River website at ir.criver.com. A webcast replay will be
accessible through the same website after each presentation and
will remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241111508820/en/
Investor Relations Contact: Todd Spencer Corporate Vice
President, Investor Relations 781.222.6455 todd.spencer@crl.com
Charles River Laboratories (NYSE:CRL)
過去 株価チャート
から 11 2024 まで 12 2024
Charles River Laboratories (NYSE:CRL)
過去 株価チャート
から 12 2023 まで 12 2024
